2017 Volume 81 Issue 12 Pages 1839-1845
Background:Initial blood ammonia level is associated with neurologic outcomes in out-of-hospital cardiac arrest (OHCA). We tested the usefulness of blood ammonia for prediction of long-term neurological outcome of OHCA.
Methods and Results:A total of 3,011 hospitalized adult OHCA patients were enrolled. Blood samples were obtained at the ED. Cut-offs (ammonia <100 μmol/L and lactate <12 mmol/L) were determined in a previous study. Neurological outcomes in survivors were assessed at 3 months. A logistic regression model with adjustment for within-hospital clustering and other risk factors was used to evaluate the association between biomarkers and outcomes. Of 3,011 patients, 380 (13.8%) had favorable neurological outcomes. Ammonia and lactate predicted neurological outcome with an AUC of 0.80 (95% CI: 0.76–0.84) and 0.77 (95% CI: 0.72–0.82), respectively. Adjusted OR for ammonia <100 μmol/L (4.55; 95% CI: 2.67–7.81) was higher than that for lactate <12 mmol/L (2.63; 95% CI: 1.61–4.28) and most other risk factors, such as cardiac etiology (3.47; 95% CI: 2.55–4.72), age<80 years (3.16; 95% CI: 2.17–4.61), bystander CPR (2.39; 95% CI: 1.70–3.38), and initial rhythm shockable (1.66; 95% CI: 1.16–2.37). The combination of ammonia and lactate had an increased predictive value (AUC, 0.86; 95% CI: 0.85–0.87) compared with that without biomarkers (AUC, 0.81; 95% CI: 0.80–0.82).
Conclusions:Initial blood ammonia level is as useful as other traditional prognostic indicators such as lactate. Measurement of both initial blood ammonia and lactate helped accurately predict neurological outcomes after OHCA.
